Coagulation Factor VIII (F8) (C-Term) Peptide
Quick Overview for Coagulation Factor VIII (F8) (C-Term) Peptide (ABIN976555)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- GSKGEKGERG RAGELGEAGP SGEPGVPGDA GMPGERGEAG HRGSAGALGP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-F8 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Factor VIII (F8) (Coagulation Factor VIII (F8))
-
Background
-
This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3.
Alias Symbols: AHF, DXS1253E, F8B, F8C, FVIII, HEMA
Protein Interaction Partner: COL2A1,MAG,EGFR
Protein Size: 684 -
Molecular Weight
- 63 kDa
-
Gene ID
- 2157
-
NCBI Accession
- NM_000132, NP_000123
-
UniProt
- P00451
Target
-